NovoCure Limited Ordinary Shares (NVCR) — Analysis Summary
NovoCure Limited Ordinary Shares (NVCR) has a market cap of $1.97B with year-over-year revenue growth of +8.3%. Net margin stands at -20.8%. The stock trades at a P/E ratio of -11.4.
Key Takeaways
- Revenue changed +8.3% year-over-year
- Net margin of -20.8%
- P/E ratio of -11.4
Compared to other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, NVCR posted revenue growth of +8.3% and trades at a P/E of -11.4.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.